Gustafson Line Winther, Krog Louise, Sardini Bayan, Tranberg Mette, Petersen Lone Kjeld, Andersen Berit, Bor Pinar, Hammer Anne
University Research Clinic for Cancer Screening, Department of Public Health Programmes, Randers Regional Hospital, Randers, Denmark.
Department of Obstetrics and Gynecology, Aarhus University Hospital, Aarhus, Denmark.
Acta Obstet Gynecol Scand. 2025 Feb;104(2):342-349. doi: 10.1111/aogs.15019. Epub 2025 Jan 2.
Diagnostic work-up of older women with a positive cervical cancer screening test is often challenging due to incomplete visualization of the transformation zone. To reduce the risk of missing disease, a diagnostic cervical excision may be performed. However, little is known on treatment efficacy and post-treatment surveillance for older women. We aimed to investigate the proportion of women testing negative for human papillomavirus (HPV) following a diagnostic cervical excision due to an abnormal screening test.
We conducted a prospective cohort study on women aged ≥45 years who were referred for colposcopy due to an abnormal screening test between March 2019 and June 2021. All women had incomplete visualization of the transformation zone and underwent colposcopy and a diagnostic cervical excision at the first visit. Women were followed from date of excision until January 30, 2023. Follow-up data was retrieved from the Danish Pathology Databank, and baseline characteristics were obtained from medical records. Cox regression was used on interval-censored data to estimate crude and adjusted hazard ratios for a negative HPV test after cervical excision, stratified by histology and age.
A total of 100 women underwent a diagnostic cervical excision and had at least one HPV test during follow-up. Median age was 67.4 years, and median follow-up time was 2.9 years. At the end of follow-up, 70% tested HPV negative. Women with cervical intraepithelial neoplasia grade two or worse in their excision specimen were more likely to test HPV negative at the first test after cervical excision compared to women with less than cervical intraepithelial neoplasia grade two, however, not statistically significant (adjusted hazard ratio 1.69, 95% CI 0.92-3.10). Women aged 65-84 years were less likely to test HPV negative compared to women <65 years (adjusted hazard ratio 0.49, 95% CI 0.28-0.87).
In older women undergoing a diagnostic cervical excision, 70% tested HPV negative after 2.9 years, leaving 30% with persistent HPV positivity. More studies are needed to determine the risks associated with continued HPV positivity in the absence of high-grade disease. Furthermore, given the absence of specific guidelines, the optimal surveillance frequency remains unknown.
由于转化区可视化不完整,对宫颈癌筛查试验呈阳性的老年女性进行诊断性检查往往具有挑战性。为降低漏诊疾病的风险,可能会进行诊断性宫颈切除术。然而,对于老年女性的治疗效果和治疗后监测知之甚少。我们旨在调查因筛查试验异常而接受诊断性宫颈切除术后人乳头瘤病毒(HPV)检测呈阴性的女性比例。
我们对2019年3月至2021年6月期间因筛查试验异常而转诊接受阴道镜检查的≥45岁女性进行了一项前瞻性队列研究。所有女性的转化区可视化均不完整,在首次就诊时接受了阴道镜检查和诊断性宫颈切除术。从切除日期开始对女性进行随访,直至2023年1月30日。随访数据从丹麦病理数据库中获取,基线特征从医疗记录中获得。对区间删失数据使用Cox回归,按组织学和年龄分层,估计宫颈切除术后HPV检测呈阴性的粗风险比和调整后风险比。
共有100名女性接受了诊断性宫颈切除术,并且在随访期间至少进行了一次HPV检测。中位年龄为67.4岁,中位随访时间为2.9年。随访结束时,70%的女性HPV检测呈阴性。与切除标本中宫颈上皮内瘤变二级或更严重程度低于二级的女性相比,切除标本中宫颈上皮内瘤变二级或更严重的女性在宫颈切除术后首次检测时更有可能HPV检测呈阴性,然而,差异无统计学意义(调整后风险比为1.69,95%置信区间为0.92 - 3.10)。与年龄<65岁的女性相比,65 - 84岁的女性HPV检测呈阴性的可能性较小(调整后风险比为0.49,95%置信区间为0.28 - 0.87)。
在接受诊断性宫颈切除术的老年女性中,2.9年后70%的女性HPV检测呈阴性,30%的女性HPV持续呈阳性。需要更多研究来确定在无高级别疾病情况下持续HPV阳性相关的风险。此外,由于缺乏具体指南,最佳监测频率仍然未知。